Precision Biosciences DTIL

Health care sectorNasdaq

Company

Exchange: Nasdaq
Sector: Health care
Industry: Biological Products, (No Diagnostic Substances)
Headquarters: Durham, North Carolina
Fiscal year end: 05/21
Next earnings: 10/16, estimated

No member of Congress reported a trade in Precision Biosciences DTIL in the past 90 days. Insiders filed 3 purchases and 0 sales on the open market over the same period, a net purchase of $29.5K.

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: No record; Last 90 days · 0 buys · 0 sales
Insider net buying: +$29.5K; Last 90 days · bought $29.5K · sold $0
Next earnings: 10/16; Estimated from the last four quarters

26-week trading

Common questions

Did Precision Biosciences DTIL insiders buy or sell in the past 90 days?: In the past 90 days insiders filed 3 purchases and 0 sales on the open market. Purchases came to $29.5K.